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Abstract. H. perforatum L. is widely used for the treatment of mild to moderate forms of
depression. The aim of the present study is to compare the antidepressive effect of the H. perforatum
to H. maculatum, the most widely spread species from Romania. The powdered aerial parts of vegetal
product were extracted with ethanol 70°, minimum content in total hypericins for the medicinal drug
were determined by a spectrophotometer method. The experiment was carried out on 15 female Swiss
mice, divided in three equal groups, H. perforatum group, H. maculatum group and control. The both
extracts were injected 30 minutes before the experiment, 70 mg DS/kg body weight. Forced
Swimming Test (FST) was performed by using the classic Porsolt’s method, with minor changes. Both
extracts (H. perforatum and H. maculatum) increase the immobility time as compared to control, the
difference were distinct statistically significant; so, unexpectedly Hypericum sp. alcoholic extracts
provide similar sedative effect.
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INTRODUCTION
Hypericum perforatum L. (Hypericaceae), commonly known as St. John’s wort, is one
of the best investigated medicinal plants. H. perforatum is widely used for the treatment of
mild to moderate forms of depression. Some well documented clinical studies (Brenner et al.,
2000, De Vry et al., 1999) had shown that alcoholic extract from these plants have at least the
same efficiency as the conventional drugs but with far less side effects. It has been suggested
that H. maculatum has antipanic and anxiolitic effects on human subjects (Bach-Rojecky et
al., 2004).
Aerial parts of Hypericum species contain the following active substances:
naphtodiantrons 0.1-0.5% (hypericin, pseudohypericin and their isomers), flavonoids 4-5%
(hyperoside, rutoside, quercitroside, biapigenin), tannins 10-20%, hyperforin,
proanthocyanins, caffeic acid derivatives, xanthons, essential oil 0.1-1% etc (Herman and
Gheorgiu, 1961). The main active components of Hypericum sp. are thought to be hypericin
and hyperforin, but other common plant constituents (e.g., flavonoids and flavonoid
derivatives, xanthone derivatives, amentoflavone, biapigenin, volatile oil) that may have
antidepressant effects. Although additional research is needed to definitively understand the
effects of these components alone and in combination, most available Hypericum sp.
formulations are now standardized to include hypericin (range: 0.1 to 0.4 %) and hyperforin
(range: 2.0 to 4.0 %) because these constituents have been studied the most extensively.
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In Romania’s spontaneous flora are mentioned 12 species of Hypericum (Stănescu et.
al., 2004), the most widely spread, and used species are H. perforatum L. (in the hills regions)
and H. maculatum C. (in the mountain regions) Tămaş et al. (2001); H. maculatum is also
harvested in order to obtain Hyperici herb (Ciulei et al. 1993). Both Romanian
Pharmacopoeia (R.Ph. 1993) and European Pharmacopoeia (E. Ph. 2008) accept as officinal
only H. perforatum L, therefore the aim of the present study is to compare the antidepressive
effect of the H. perforatum to H. maculatum, the most widely spread species from Romania.
Among all animal models, the Forced Swimming Test (FST) (Porsolt et al., 1977)
remains one of the most used tools for screening antidepressants (Petit-Demouliere et al.,
2005). This experiment is aiming to test the antidepressant efficiency of H. maculatum and H.
perforatum alcoholic extract (700) on Swiss mice trough FST.
MATERIALS AND METHODS
Plant materials: the aerial parts of H. perforatum were harvested from Chiribiş (Bihor
County) and the aerial parts of H. maculatum were harvested from Ciucea (Cluj County) in
the blossom period, in June 2008. The vegetal products were dried and grounded to a fine
powder (sieve VI - R. Ph. 1993) (Istudor, 1998).
Preparation of tinctures: 10g of powdered aerial parts of vegetal product were
extracted with 100 g of ethanol 70° at room temperature, as described in Romanian
Pharmacopoeia Xth Edition.
In E. Ph. 2008 it is mentioned as minimum content in total hypericins for the
medicinal drug Hyperici herb 0.08%, determined by a spectrophotometer method and a
qualitative analysis by TLC (York et al., 1990) in order to identify the flavonoids and
hypericin
To prevent toxic effect of the alcohol, often more toxic than plant compounds
dissolved in it, alcoholic solution was maintained at 70˚C until half of the content evaporates,
than filed with sterile saline solution up to 5 ml for each mouse. The aqueous solution was
administrated intraperitoneally immediately in order to prevent the bacterial and fungus
contamination.
The animals were caged in groups of 5 per cage, at controlled temperature of 21-22ºC,
humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard lab
chow, provided by National Institute for Research and Development “Cantacuzino” Bucharest
(Batch no. 2 / 26.03.2010), and water were freely available. The permission for the animal
tests and experiments has been given by the Bioethical Board of the Faculty of Veterinary
Medicine Cluj-Napoca.
The experiment was carried out on 15 female Swiss mice, 3 months old and 30±3 g
average body weight. The animals were divided in three equal groups, H. perforatum group,
H. maculatum group and control. The extracts were injected 30 minutes before the
experiment, 70 mg DS/kg body weight, for each extract in study, while control mice received
ethanol 70°, subject to the same procedure of evaporation. .
Forced Swimming Test, (FST) was performed by using the classic Porsolt’s method
(Porsolt et al., 1977), with minor changes as follows; the glass recipients, 15 l each, have had
30 cm in diameter, they were wrapped in black plastic foil so the animal, could not see
outside the recipient. In every recipient it was poured taped water at a controlled temperature
of 23±1˚C and 20 cm height. Subsequently it was introduced one mouse at a time in each one,
giving it 2 min to adjust to the environment, then it was clocked the immobility time for the
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next 4 min, meaning the time in which the mouse sat still or made only little movement
necessary to keep its head above the water (Bach-Rojecky et al., 2004, Petit-Demouliere et
al., 2005, David et al., 2003, Porsolt, 2000,). After that the mouse was removed from the
recipient, dried up with a towel and put in a dry cage.
Statistics - the data were expressed as the mean and standard deviation. T Student
multiple range test from Excel Windows Software was used to assess the differences among
groups. Differences at p<0.05 and p<0.01 were considered significant and respectively
distinct significant.
RESULTS AND DISCUSSION
Surprisingly, both extracts (H. perforatum and H. maculatum) increase the immobility
time as compared to control, the difference were distinct statistically significant (p<0.01)
(fig.1); therefore, in the present study, it had been shown that alcoholic extracts of both
Hypericum sp., induce an depressant-like effect in FST.
Fig. 1:The immobility time (mean ± S.D.) (sec).
*= statistically distinct significant at p<0.01 as compared to Control group
The immobility displayed in rodents subjected to an unavoidable and inescapable
stress has been hypothesized to reflect behavioral despair, which in turn may reflect
depressive disorders in humans. In FST, a prolonged exposure to an aversive situation induces
immobility, interpreted as an expression of “behavioral despair”, which could also be related
to a depression syndrome (Porsolt, 2000, Porsolt et al., 1977). Other studies found that after a
single administration of the extract in doses of 7, 35, 70 mg kg b.m. suspension, showed that
the immobility time of animals decreased dose-dependently, namely, the animals were more
active, which means that the antidepressant effect was stronger (Bach-Rojecky et al., 2004).
However, H. perforatum seems to have different effects according to the doses, it
increase motor activity at 10 mg/kg and to decrease it at the highest dose injected (200
mg/kg). The results do not confirm other findings, according to which high doses of H.
perforatum increase activity in Open Field Test (Giovanni et al., 2007).
118
Muller et al. (2003) have suggested that Hypericum sp. acts via inhibition of the
reuptake of serotonin, dopamine and noradrenaline, along with activation of gamma-
aminobutyrate and glutamate receptors. At high dosages, hypericin is a monoamine oxidase
inhibitor; however, these effects have not been demonstrated with the consumption of
Hypericum sp. at dosages recommended for the treatment of depression (Lawvere and
Mahoney, 2005). On the other hand, it has been reported that hyperforin, increases the release
of striatal acetylcholine (Mennini and Gobbi, 2004); if confirmed by analytical studies, a
substantial concentration of hyperforin might explain not only the reduced locomotor activity
induced by H. perforatum, but, also, in H. maculatum.
CONCLUSIONS
Hypericum sp. alcoholic extracts (H. perforatum and H. maculatum) provide similar
sedative effect; both of them significantly increase the immobility time in FST.
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